PuraPharm Corporation Limited (HKG:1498)
Hong Kong · Delayed Price · Currency is HKD 0.3050
0.00 (0.00%)
Apr 2, 2026, 2:43 PM HKT
PuraPharm Corporation Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -35.44 | -106.08 | -120.21 | -121.88 |
Depreciation & Amortization | 52.49 | 45.57 | 45.83 | 47.26 |
Other Amortization | 2.1 | 5.33 | 4.2 | 3.13 |
Loss (Gain) From Sale of Assets | -1 | 1.29 | -0.04 | -0.18 |
Asset Writedown & Restructuring Costs | 2.77 | 32.71 | 41.3 | 116 |
Loss (Gain) From Sale of Investments | -1.44 | 0 | -0.17 | -0.3 |
Loss (Gain) on Equity Investments | 0.31 | 0.15 | - | - |
Stock-Based Compensation | 1.45 | 4.29 | 0.27 | 3.5 |
Provision & Write-off of Bad Debts | -1 | 2.73 | 10.55 | 17.03 |
Other Operating Activities | 30.41 | 31.61 | 25.63 | 34.16 |
Change in Accounts Receivable | 23.61 | 47.09 | 105.45 | -51.19 |
Change in Inventory | 50.37 | -6.44 | -17.23 | 4.68 |
Change in Accounts Payable | -10.81 | 10.47 | 9.61 | -22.56 |
Change in Unearned Revenue | 0.86 | -0.01 | -2.05 | -3.22 |
Change in Income Taxes | - | 5.84 | -4.17 | - |
Change in Other Net Operating Assets | -10.69 | 5.08 | -10.45 | -40.94 |
Operating Cash Flow | 103.99 | 79.61 | 88.51 | -14.52 |
Operating Cash Flow Growth | 30.62% | -10.05% | - | - |
Capital Expenditures | -14.81 | -19.18 | -20.83 | -3.09 |
Sale of Property, Plant & Equipment | 3.48 | - | 0.1 | 2.89 |
Sale (Purchase) of Intangibles | -1.58 | -2.48 | -1.89 | -3.47 |
Investment in Securities | - | -0.63 | -1.98 | - |
Other Investing Activities | 1.19 | 4.09 | -6.64 | 9.67 |
Investing Cash Flow | -11.71 | -18.2 | -31.25 | 6.01 |
Short-Term Debt Issued | 3 | - | 5.55 | 2.16 |
Long-Term Debt Issued | 200.19 | 253.03 | 342.11 | 374.88 |
Total Debt Issued | 203.19 | 253.03 | 347.66 | 377.05 |
Short-Term Debt Repaid | - | -7.71 | - | - |
Long-Term Debt Repaid | -266.38 | -340.29 | -359.87 | -363.89 |
Total Debt Repaid | -266.38 | -348 | -359.87 | -363.89 |
Net Debt Issued (Repaid) | -63.18 | -94.97 | -12.21 | 13.16 |
Issuance of Common Stock | - | - | 0.8 | - |
Other Financing Activities | -23.25 | -27.42 | -24.18 | -27.03 |
Financing Cash Flow | -86.43 | -122.39 | -35.59 | -13.87 |
Foreign Exchange Rate Adjustments | -13.18 | 5.28 | -5.51 | 6.25 |
Net Cash Flow | -7.33 | -55.71 | 16.16 | -16.14 |
Free Cash Flow | 89.18 | 60.43 | 67.68 | -17.61 |
Free Cash Flow Growth | 47.58% | -10.72% | - | - |
Free Cash Flow Margin | 23.34% | 14.85% | 15.10% | -2.67% |
Free Cash Flow Per Share | 0.23 | 0.15 | 0.17 | -0.04 |
Cash Interest Paid | 23.25 | 27.42 | 24.18 | 27.03 |
Cash Income Tax Paid | -0.15 | 2.3 | 4.5 | 4.85 |
Levered Free Cash Flow | 65.88 | 83.52 | 82.33 | -36.52 |
Unlevered Free Cash Flow | 80.7 | 100.65 | 97.44 | -19.63 |
Change in Working Capital | 53.33 | 62.02 | 81.17 | -113.24 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.